Mandeep Bath, MD
Family Medicine · Bakersfield, CANPI 1205494846
Payments from drug & device makers
Across 34 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$85
- Merck$76
- Dynavax Technologies Corporation$62
- Lilly USA, LLC$61
- Dexcom, Inc.$52
- Exact Sciences$39
- plus $247 from 11 others
What the payments were for
- Food & beverage$623100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 5 | $85 |
| Merck | 4 | $76 |
| Dynavax Technologies Corporation | 3 | $62 |
| Lilly USA, LLC | 4 | $61 |
| Dexcom, Inc. | 2 | $52 |
| Exact Sciences | 2 | $39 |
| GSK | 2 | $34 |
| AstraZeneca | 2 | $28 |
| Boehringer Ingelheim | 1 | $25 |
| AbbVie | 1 | $25 |
| Pfizer | 1 | $25 |
| Phathom Pharmaceuticals, Inc. | 2 | $21 |
| Qiagen, LLC | 1 | $21 |
| Vertex | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $15 |
How this compares
$623 in reported general payments places this provider in the 65th percentile of 10,533 family medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 70 | $611 |
| Metoprolol Succinate | 16 | $361 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $360 |
| Rosuvastatin Calcium | 19 | $315 |
| Amlodipine Besylate | 48 | $264 |
| Omeprazole | 27 | $254 |
| Metformin Hcl | 35 | $164 |
| Levothyroxine Sodium | 19 | $141 |
| Lisinopril | 38 | $137 |
| Losartan Potassium | 14 | $108 |
| Gabapentin | 14 | $81 |
| Alendronate Sodium | 16 | $78 |
| Simvastatin | 13 | $70 |
| Hydrochlorothiazide | 22 | $45 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Bakersfield
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
- Suzanne FussellOxnard$8.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.